E. Ehrnrooth

Association of perceived physician communication style with patient satisfaction, distress, cancer-related self-efficacy, and perceived control over the disease

Robert Zachariae, Charlotte Gjørup Pedersen, Anders Bonde Jensen et al. · British Journal of Cancer · 2003 · 600 citations · Full text

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Jean-Pascal H. Machiels, Robert I. Haddad, Jérôme Fayette et al. · The Lancet Oncology · 2015 · 386 citations

Neoadjuvant Therapy, Neck 1, Randomised Phase 3 +10

A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma

Julie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Evelina Martinenaite et al. · Nature Medicine · 2021 · 197 citations · Full text

A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck

Tanguy Y. Seiwert, Jérôme Fayette, Didier Cupissol et al. · Annals of Oncology · 2014 · 178 citations · Full text

The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors

Michael R. Horsman, E. Ehrnrooth, Morten Ladekarl et al. · International Journal of Radiation Oncology*Biology*Physics · 1998 · 94 citations

Murine Spontaneous Tumors, Tumor Biology, Oncology +9